SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following a strong Q2 earnings report that showcased 250% year-over-year revenue growth, fueling optimism around its accelerating expansion into high-performance computing. The community is actively discussing the significant pipeline of new data center capacity and anticipated hyperscaler lease announcements, positioning APLD as a key player in the AI infrastructure sector. Despite some short-term price fluctuations attributed by many to market manipulation, a strong bullish sentiment persists for its long-term growth potential.

flyExclusive, Inc. engages in owning and operating jet aircraft for private jet passengers. It manages all aspects of the customer experience, in-house maintenance, repair, and overhaul services, including paint, interiors, and avionics capabilities. The company was founded by Thomas James Segrave, Jr. in 2015 and is headquartered in Kinston, NC.

flyExclusive Inc. - Ordinary Shares - Class A

flyExclusive is trending following news of its authorized dealership agreement with Starlink, positioning the private jet operator to install high-speed satellite internet across its fleet and for third parties. This development is sparking intense community discussion, with many actively debating its low float and the potential for a significant short squeeze. Traders are keenly observing its volatility, anticipating further price action.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving positive FDA feedback, confirming no additional clinical trials are needed for its lead drug, sonelokimab, to support a Biologics License Application for hidradenitis suppurativa. This crucial regulatory clarity is fueling investor optimism, with the community viewing it as a significant de-risking event for the asset. Many anticipate substantial analyst price target upgrades and renewed speculation about a potential buyout, particularly from Merck, given the drug's market opportunity.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to preliminary financial guidance for upcoming years projecting a decrease in DefenCath revenue, leading to a sharp market reaction and significant community debate. While many investors express frustration and question management's approach, others argue that the revenue adjustments for the post-TDAPA period were anticipated and the sell-off is an overreaction. The conversation highlights the ongoing strategic importance of the company's diversified portfolio and pipeline assets like REZZAYO, alongside discussions of potential short squeeze dynamics.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc. is trending after announcing triple-digit growth for its AI back pain platform, a strong cash position, and no debt, extending its cash runway into 2027. The community is buzzing with speculation about a potential short squeeze, given its low float and perceived high short interest, drawing comparisons to past high-flying small-cap runners. Many investors are eyeing significant upside, believing the stock is undervalued based on its fundamentals and the potential of its diagnostic technology.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind is notably trending following a business update highlighting a record revenue quarter and anticipation of multiple upcoming FDA decisions for its Afrezza and FUROSCIX products. While investors are enthusiastic about future growth catalysts and M&A speculation, there's ongoing community debate regarding past stock performance and insider share transactions.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is experiencing heightened attention driven by a recent analyst upgrade and its strategic move to integrate advanced driving technology into more accessible electric vehicles. The community is actively weighing the company's strong overall sales performance, particularly in hybrids and trucks, against its significant pivot away from some prior electric vehicle strategies. This re-focus on profitability and a balanced product lineup is sparking both bullish sentiment for future margins and ongoing debate about market execution.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is experiencing a significant upward price movement and surging trading volume, fueling intense community debate around its near-term trajectory. Proponents emphasize its foundational utility in Japan's digital identity and IoT sector, backed by ex-Sony leadership and regulatory compliance, as indicators of a sustained breakout. Conversely, skeptics caution that the rally could be another transient event given its historical volatility and past supply dilution.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending with its highly engaged community actively promoting it as the next dominant multi-chain meme coin. The project highlights its deflationary burn mechanism across various bridges and strategic partnerships, fueling discussions around its organic growth. The community expresses an ambitious goal for $CAW to become the leading meme coin by surpassing established contenders like Dogecoin and Shiba Inu.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.31, indicating a +1.96% shift from the previous trading day.

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer...

Ginkgo Bioworks (NYSE:DNA) Trading Up 10% - Time to Buy?

Ginkgo Bioworks (NYSE:DNA) Shares Up 10% - Here's Why...

Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing...

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety PR...

Ginkgo Bioworks (NYSE:DNA) Shares Gap Up - What's Next?

Ginkgo Bioworks (NYSE:DNA) Shares Gap Up - Time to Buy...

Ginkgo Bioworks Selected by PNNL to Deliver a Modular, HighThroughput Phenotyping Platform for DOE's M2PC

Ginkgo Bioworks Selected by PNNL to Deliver a Modular, HighThroughput Phenotyping Platform for DOE's M2PC Ginkgo Bioworks Selected by PNNL to Deliver a Modular, HighThroughput Phenotyping Platform...

Ginkgo Bioworks Holdings, Inc. $DNA Holdings Boosted by Geode Capital Management LLC

Geode Capital Management LLC raised its stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 104.5% in the second quarter, according to the company in its most recent disclosure with...

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health...

Ginkgo Bioworks (NYSE:DNA) Releases Earnings Results, Misses Expectations By $0.21 EPS

Ginkgo Bioworks (NYSE:DNA - Get Free Report) released its earnings results on Thursday. The company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.24) by ($0.21). Ginkgo...

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DNA News

DNAGinkgo Bioworks Holdings Inc - Ordinary Shares - Class A